[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100528403":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":12,"locations":22,"responsibleParty":40,"collaborators":7,"id":44,"slug":7,"hasResults":45,"nctId":46,"briefTitle":47,"officialTitle":48,"acronym":7,"eligibilityCriteria":49,"healthyVolunteers":45,"sex":50,"minAge":7,"maxAge":7,"enrollmentInfo":51,"targetDuration":54,"studyType":55,"phases":7,"briefSummary":56,"conditions":57,"keywords":60,"overallStatus":25,"whyStopped":7,"lastUpdateSubmitDate":63,"lastUpdatePostDateStruct":64,"startDateStruct":67,"completionDateStruct":69,"leadSponsor":71,"locationsCount":72},{"fullName":5,"class":6},"Children's Hospital Medical Center, Cincinnati","OTHER",null,[9],{"name":10,"affiliation":5,"role":11},"David M Ritter, MD, PhD","PRINCIPAL_INVESTIGATOR",[13,18],{"name":14,"role":15,"phone":16,"phoneExt":7,"email":17},"Molly S Griffith, BA","CONTACT","513-636-9669","molly.griffith@cchmc.org",{"name":19,"role":15,"phone":20,"phoneExt":7,"email":21},"Adrienne Victory","513-636-8016","adrienne.victory@cchmc.org",[23],{"facility":24,"status":25,"city":26,"state":27,"zip":28,"country":29,"cosmosGeoPoint":30,"geoPoint":35,"contacts":36},"Cincinnati Children's Hospital Medical Center","RECRUITING","Cincinnati","Ohio","45229","United States",{"type":31,"coordinates":32},"Point",[33,34],-84.51439,39.12711,{"lat":34,"lon":33},[37,38,39],{"name":14,"role":15,"phone":16,"phoneExt":7,"email":17},{"name":19,"role":15,"phone":20,"phoneExt":7,"email":21},{"name":10,"role":11,"phone":7,"phoneExt":7,"email":7},{"type":41,"investigatorFullName":42,"investigatorTitle":43,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"SPONSOR_INVESTIGATOR","David M. Ritter","Sponsor\u002FPrincipal Investigator","100528403",false,"NCT06160310","Tuberous Sclerosis Complex and Lymphangioleiomyomatosis Pregnancy Registry (TSC-LAM Registry)","Tuberous Sclerosis Complex and Lymphangioleiomyomatosis Pregnancy Registry","Inclusion Criteria:\n\n* A pregnant woman with a clinical or genetic diagnosis of TSC as determined by the 2021 Consensus Guidelines (1)\n* A pregnant woman with a diagnosis of LAM\n* A pregnant woman with a variant of uncertain significance in TSC 1 or TSC 2\n* A pregnant woman who is pregnant and the fetus has a 50% chance of TSC as deemed by the PI or Sub-Is\n* A pregnant woman whose fetus is found to have concern for TSC secondary to rhabdomyomas, tubers, or congenital subependymal giant cell astrocytoma.\n* An infant born to an enrolled individual.\n\nExclusion Criteria:\n\n* A pregnant woman without TSC who has used preimplantation genetic testing for TSC unless qualifies under inclusion criteria #4.\n* Infants diagnosed with TSC whose birth mother was not enrolled.","FEMALE",{"count":52,"type":53},300,"ESTIMATED","5 Years","OBSERVATIONAL","This study is an observational registry designed to gather information about Tuberous Sclerosis Complex (TSC) and Lymphangioleiomyomatosis (LAM) in pregnant women and their child.",[58,59],"Tuberous Sclerosis Complex","Lymphangioleiomyomatosis",[58,61,59,62],"TSC","LAM","2026-01-21",{"date":65,"type":66},"2026-01-23","ACTUAL",{"date":68,"type":66},"2023-07-01",{"date":70,"type":53},"2029-07-01",{"name":42,"class":6},1]